NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Neos Therapeutics To Participate In Three September Conferences August 29, 2017 Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017 W. L. Gore & Associates Release: GORE VIATORR TIPS Endoprosthesis With Controlled Expansion May Reduce Portal Hypertension Readmissions In Ongoing Study July 31, 2017
Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017
W. L. Gore & Associates Release: GORE VIATORR TIPS Endoprosthesis With Controlled Expansion May Reduce Portal Hypertension Readmissions In Ongoing Study July 31, 2017
